Improving bone marrow transplants in mice to help fight disease

lab mice
Credit: Pixabay/CC0 Public Domain

To study the immune system in human health and disease, scientists commonly use the genetic manipulation of mouse hematopoietic stem and progenitor cells (HSPCs) as a powerful model system. These studies have been extremely valuable in the fight against a number of human diseases. However, the current procedures are complex, time-consuming, and expensive.

In a new study published in Nature Communications, researchers at the University of Tsukuba have developed a novel technique that has the potential to overcome the limitations associated with these models, which are known as (BM) chimeric mice. This system allows scientists to observe and investigate how genetic alterations affect immune cell phenotypes and behaviors in a physiological setting.

The first step of generating BM chimeric mice is using irradiation to destroy the of the host mouse. BM is then acquired from a donor mouse and HSPCs are isolated using a process called fluorescence-activated cell sorting (FACS). Next, the HSPCs are genetically manipulated and then engrafted in the irradiated host mouse, where they reconstitute the immune system. This process has some shortcomings, including the expense of FACS and the technical expertise needed to perform it. Furthermore, irradiation can detrimentally affect the mouse's health, even following immune system reconstitution. For these reasons, the University of Tsukuba research group aimed to address these downfalls with a new method.

"BM chimeric mice are extremely useful in the immunology field," says Professor Satoshi Yamazaki, senior author of the study. "We wanted to optimize this model to improve animal welfare and reduce the need for specialized equipment."

The team developed a specific cell culture medium that was used to grow HSPCs in the lab. This medium was supplemented with certain stimulating molecules, called and cytokines, that promoted the growth of the HSPCs in culture.

"Growth of HSPCs in our newly formulated medium eliminated the need for FACS," explains Professor Yamazaki. "We could also genetically manipulate HSPCs within this culture system."

Additionally, the authors explained how these cultured HSPCs can be successfully engrafted in non-conditioned immunocompetent recipient mice. This means that the host do not need to be irradiated, eliminating the negative experimental and toxic effects associated with this process.

Overall, this groundbreaking approach can be applied to study the immune system in both healthy and diseased states and will help to facilitate a more cost-effective, safe, and scientifically rigorous method.

More information: Kiyosumi Ochi et al, Non-conditioned bone marrow chimeric mouse generation using culture-based enrichment of hematopoietic stem and progenitor cells, Nature Communications (2021). DOI: 10.1038/s41467-021-23763-z

Journal information: Nature Communications
Citation: Improving bone marrow transplants in mice to help fight disease (2021, June 11) retrieved 18 May 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

How bone marrow regenerates after chemotherapy


Feedback to editors